Erratum: Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite (ACS Nano (2015) 9:10 (9614-9625) DOI: 10.1021/nn507485j);Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite

ACS Nano

Volumn 9, Issue 10, 2015, Pages 9614-9625

  Hao, Xiaohong ^a   Hu, Xixue ^b   Zhang, Cuimiao ^a   Chen, Shizhu ^a   Li, Zhenhua ^a   Yang, Xinjian ^a   Liu, Huifang ^a   Jia, Guang ^a   Liu, Dandan ^a   Ge, Kun ^a   Liang, Xing Jie ^b   Zhang, Jinchao ^a  

^a HEBEI UNIVERSITY   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

anticancer drug carrier; biodegradability; pH sensitivity; silica hydroxyapatite hybrid nanoparticles

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; BIODEGRADABILITY; DRUG PRODUCTS; HYDROXYAPATITE; MESOPOROUS MATERIALS; PH SENSORS; SILICA NANOPARTICLES; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

ANTICANCER DRUG; BIOLOGICAL EXPERIMENTS; DRUG DELIVERY SYSTEM; HIGH DRUG LOADINGS; HYBRID NANOPARTICLE; MESOPOROUS SILICA NANOPARTICLES; MORPHOLOGY AND STRUCTURES; PH SENSITIVITY;

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG CARRIER; HYDROXYAPATITE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL; BREAST; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; FEMALE; METABOLISM; MOUSE; PATHOLOGY; POROSITY; ULTRASTRUCTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST; BREAST NEOPLASMS; DOXORUBICIN; DRUG CARRIERS; DURAPATITE; FEMALE; MICE; NANOPARTICLES; POROSITY; SILICON DIOXIDE;

EID: 84945905478     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.6b00543     Document Type: Erratum

References (48)

1. Timko, B. P.; Whitehead, K.; Gao, W. W.; Kohane, D. S.; Farokhzad, O.; Anderson, D.; Langer, D. Advances in Drug Delivery Annu. Rev. Mater. Res. 2011, 41, 1-20 10.1146/annurev-matsci-062910-100359
2. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis Adv. Drug Delivery Rev. 2002, 54, 631-651 10.1016/S0169-409X(02)00044-3
3. Haley, B.; Frenkel, E. Nanoparticles for Drug Delivery in Cancer Treatment Urol. Oncol.-Semin.Origi. 2008, 26, 57-64 10.1016/j.urolonc.2007.03.015
4. Lasic, D. D. Novel Applications of Liposomes Trends Biotechnol. 1998, 16, 307-321 10.1016/S0167-7799(98)01220-7
5. Liechty, W. B.; Peppas, N. A. Expert Opinion: Responsive Polymer Nanoparticles in Cancer Therapy Eur. J. Pharm. Biopharm. 2012, 80, 241-246 10.1016/j.ejpb.2011.08.004
6. Huo, S. D.; Ma, H. L.; Huang, K. Y.; Liu, J.; Wei, T.; Jin, S. B.; Zhang, J. C.; He, S. T.; Liang, X. J. Superior Penetration and Retention Behavior of 50 nm Gold Nanoparticles in Tumors Cancer Res. 2013, 73, 319-330 10.1158/0008-5472.CAN-12-2071
7. Parveen, S.; Misra, R.; Sahoo, S. K. Nanoparticles: A Boon to Drug Delivery, Therapeutics, Diagnostics and Imaging Nanomedicine 2012, 8, 147-166 10.1016/j.nano.2011.05.016
8. De Jong, W. H.; Borm, P. J. A. Drug Delivery and Nanoparticles: Applications and Hazards Int. J. Nanomed. 2008, 3, 133-149 10.2147/IJN.S596
9. Dasgupta, S.; Banerjee, S. S.; Bandyopadhyay, A.; Bose, S. Zn- and Mg-Doped Hydroxyapatite Nanoparticles for Controlled Release of Protein Langmuir 2010, 26, 4958-4964 10.1021/la903617e
10. Meng, H. A.; Liong, M.; Xia, T. A.; Li, Z. X.; Ji, Z. X.; Zink, J. I.; Nel, A. E. Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line ACS Nano 2010, 4, 4539-4550 10.1021/nn100690m
11. Xia, T. A.; Kovochich, M.; Liong, M.; Meng, H.; Kabehie, S.; George, S.; Zink, J. I.; Nel, A. E. Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs ACS Nano 2009, 3, 3273-3286 10.1021/nn900918w
12. Chen, J. F.; Ding, H. M.; Wang, J. X.; Shao, L. Preparation and Characterization of Porous Hollow Silica Nanoparticles for Drug Delivery Application Biomaterials 2004, 25, 723-727 10.1016/S0142-9612(03)00566-0
13. Li, Z. Z.; Xu, S. A.; Wen, L. X.; Liu, F.; Liu, A. Q.; Wang, Q.; Sun, H. Y.; Yu, W.; Chen, J. F. Controlled Release of Avermectin from Porous Hollow Silica Nanoparticles: Influence of Shell Thickness on Loading Efficiency, UV-Shielding Property and Release J. Controlled Release 2006, 111, 81-88 10.1016/j.jconrel.2005.10.020
14. 2 -Drug Composite Nanoparticles J. Am. Chem. Soc. 2013, 135, 5709-5716 10.1021/ja3123015
15. Park, J. H.; Gu, L.; von Maltzahn, G.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Sailor, M. J. Biodegradable Luminescent Porous Silicon Nanoparticles for In Vivo Applications Nat. Mater. 2009, 8, 331-336 10.1038/nmat2398
16. Pohaku Mitchell, K. K.; Liberman, A.; Kummel, A. C.; Trogler, W. C. Iron(III)-Doped, Silica Nanoshells: a Biodegradable Form of Silica J. Am. Chem. Soc. 2012, 134, 13997-4003 10.1021/ja3036114
17. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles Mol. Pharmaceutics 2008, 5, 505-515 10.1021/mp800051m
18. He, Q.; Shi, J. Mesoporous Silica Nanoparticles Based Nano Drug Delivery Systems: Synthesis, Drug Controlled Release and Delivery, Pharmacokinetics and Biocompatibility J. Mater. Chem. 2011, 21, 5845-5855 10.1039/c0jm03851b
19. Huang, X.; Li, L.; Liu, T.; Hao, N.; Liu, H.; Chen, D.; Tang, F. The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility In Vivo ACS Nano 2011, 5, 5390-5399 10.1021/nn200365a
20. Lee, C. H.; Cheng, S. H.; Wang, Y. J.; Chen, Y. C.; Chen, N. T.; Souris, J.; Chen, C. T.; Mou, C. Y.; Yang, C. S.; Lo, L. W. Near-Infrared Mesoporous Silica Nanoparticles for Optical Imaging: Characterization and In Vivo Biodistribution Adv. Funct. Mater. 2009, 19, 215-222 10.1002/adfm.200800753
21. Lu, J.; Liong, M.; Li, Z.; Zink, J. I.; Tamanoi, F. Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals Small 2010, 6, 1794-1805 10.1002/smll.201000538
22. Dai, C.; Yuan, Y.; Liu, C.; Wei, J.; Hong, H.; Li, X.; Pan, X. Degradable, Antibacterial Silver Exchanged Mesoporous Silica Spheres for Hemorrhage Control Biomaterials 2009, 30, 5364-5375 10.1016/j.biomaterials.2009.06.052
23. Nabeshi, H.; Yoshikawa, T.; Matsuyama, K.; Nakazato, Y.; Matsuo, K.; Arimori, A.; Isobe, M.; Tochigi, S.; Kondoh, S.; Hirai, T. Systemic Distribution, Nuclear Entry and Cytotoxicity of Amorphous Nanosilica Following Topical Application Biomaterials 2011, 32, 2713-2724 10.1016/j.biomaterials.2010.12.042
24. Nabeshi, H.; Yoshikawa, T.; Matsuyama, K.; Nakazato, Y.; Tochigi, S.; Kondoh, S.; Hirai, T.; Akase, T.; Nagano, K.; Abe, Y. Amorphous Nanosilica Induce Endocytosis-dependent ROS Generation and DNA Damage in Human Keratinocytes Part. Fibre Toxicol. 2011, 8, 1 10.1186/1743-8977-8-1
25. Yamashita, K.; Yoshioka, Y.; Higashisaka, K.; Mimura, K.; Morishita, Y.; Nozaki, M.; Yoshida, T.; Ogura, T.; Nabeshi, H.; Nagano, K. Silica and Titanium Dioxide Nanoparticles Cause Pregnancy Complications in Mice Nat. Nanotechnol. 2011, 6, 321-328 10.1038/nnano.2011.41
26. Pohaku Mitchell, K. K.; Liberman, A.; Kummel, A. C.; Trogler, W. C. Iron (III)-doped, Silica Nanoshells: A Biodegradable Form of Silica J. Am. Chem. Soc. 2012, 134, 13997-14003 10.1021/ja3036114
27. Li, X.; Zhang, L.; Dong, X.; Liang, J.; Shi, J. Preparation of Mesoporous Calcium Doped Silica Spheres with Narrow Size Dispersion and Their Drug Loading and Degradation Behavior Microporous Mesoporous Mater. 2007, 102, 151-158 10.1016/j.micromeso.2006.12.048
28. Schlossbauer, A.; Warncke, S.; Gramlich, P. M. E.; Kecht, J.; Manetto, A.; Carell, T.; Bein, T. A Programmable DNA-Based Molecular Valve for Colloidal Mesoporous Silica Angew. Chem., Int. Ed. 2010, 49, 4734-4737 10.1002/anie.201000827
29. Rim, H. P.; Min, K. H.; Lee, H. J.; Jeong, S. Y.; Lee, S. C. pH-Tunable Calcium Phosphate Covered Mesoporous Silica Nanocontainers for Intracellular Controlled Release of Guest Drugs Angew. Chem., Int. Ed. 2011, 50, 8853-8857 10.1002/anie.201101536
30. Liu, J. A.; Bu, W. B.; Pan, L. M.; Shi, J. L. NIR-Triggered Anticancer Drug Delivery by Upconverting Nanoparticles with Integrated Azobenzene-Modified Mesoporous Silica Angew. Chem., Int. Ed. 2013, 52, 4375-4379 10.1002/anie.201300183
31. Bernardos, A.; Aznar, E.; Marcos, M. D.; Martinez-Manez, R.; Sancenon, F.; Soto, J.; Barat, J. M.; Amoros, P. Enzyme-Responsive Controlled Release Using Mesoporous Silica Supports Capped with Lactose Angew. Chem., Int. Ed. 2009, 48, 5884-5887 10.1002/anie.200900880
32. Aznar, E.; Marcos, M. D.; Martinez-Manez, R.; Sancenon, F.; Soto, J.; Amoros, P.; Guillem, C. pH- and Photo-Switched Release of Guest Molecules from Mesoporous Silica Supports J. Am. Chem. Soc. 2009, 131, 6833-6843 10.1021/ja810011p
33. Zhang, J.; Yuan, Z. F.; Wang, Y.; Chen, W. H.; Luo, G. F.; Cheng, S. X.; Zhuo, R. X.; Zhang, X. Z. Multifunctional Envelope-Type Mesoporous Silica Nanoparticles for Tumor-Triggered Targeting Drug Delivery J. Am. Chem. Soc. 2013, 135, 5068-5073 10.1021/ja312004m
34. Wang, Y.; Wang, K.; Zhao, J.; Liu, X.; Bu, J.; Yan, X.; Huang, R. Multifunctional Mesoporous Silica-Coated Graphene Nanosheet Used for Chemo-Photothermal Synergistic Targeted Therapy of Glioma J. Am. Chem. Soc. 2013, 135, 4799-4804 10.1021/ja312221g
35. Zhang, C.; Yang, J.; Quan, Z.; Yang, P.; Li, C.; Hou, Z.; Lin, J. Hydroxyapatite Nano- and Microcrystals with Multiform Morphologies: Controllable Synthesis and Luminescence Properties Cryst. Growth Des. 2009, 9, 2725-2733 10.1021/cg801353n
36. Zhang, C.; Li, C.; Huang, S.; Hou, Z.; Cheng, Z.; Yang, P.; Peng, C.; Lin, J. Self-Activated Luminescent and Mesoporous Strontium Hydroxyapatite Nanorods for Drug Delivery Biomaterials 2010, 31, 3374-3383 10.1016/j.biomaterials.2010.01.044
37. Ahsan, R.; Mortuza, M. G. Infrared Spectra of xCaO(1-x-z)SiO(2)zP(2)O(5) Glasses J. Non-Cryst. Solids 2005, 351, 2333-2340 10.1016/j.jnoncrysol.2005.05.030
38. Barbe, C.; Bartlett, J.; Kong, L.; Finnie, K.; Lin, H. Q.; Larkin, M.; Calleja, S.; Bush, A.; Calleja, G. Silica Particles: A Novel Drug-Delivery System Adv. Mater. 2004, 16, 1959-1966 10.1002/adma.200400771
39. Tzur-Balter, A.; Shatsberg, Z.; Becherman, M.; Segal, E.; Artzi, N. Mechanism of Erosion of Nanostructured Porous Silicon Drug Carriers in Neoplastic Tissues Nat. Commun. 2015, 6, 6208-6216 10.1038/ncomms7208
40. Tasciotti, E.; Liu, X.; Bhavane, R.; Plant, K.; Leonard, A. D.; Price, B. K.; Cheng, M. M.; Decuzzi, P.; Tour, J. M. et al. Mesoporous Silicon Particles as a Multistage Delivery System for Imaging and Therapeutic Applications Nat. Nanotechnol. 2008, 3, 151-157 10.1038/nnano.2008.34
41. Gu, L.; Hall, D. J.; Qin, Z.; Anglin, E.; Joo, J.; Mooney, D. J.; Howell, S. B.; Sailor, M. J. In Vivo Time-Gated Fluorescence Imaging with Biodegradable Luminescent Porous Silicon Nanoparticles Nat. Commun. 2013, 4, 2326 10.1038/ncomms3326
42. Yu, T.; Malugin, A.; Ghandehari, H. Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity ACS Nano 2011, 5, 5717-5728 10.1021/nn2013904
43. Slowing, I. I.; Wu, C. W.; Vivero-Escoto, J. L.; Lin, V. S. Y. Mesoporous Silica Nanoparticles for Reducing Hemolytic Activity towards Mammalian Red Blood Cells Small 2009, 5, 57-62 10.1002/smll.200800926
44. Lin, Y. S.; Haynes, C. L. Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, and Pore Integrity on Hemolytic Activity J. Am. Chem. Soc. 2010, 132, 4834-4842 10.1021/ja910846q
45. n Nanoparticles in Tumor-Bearing Mice Biochem. Pharmacol. 2006, 71, 872-881 10.1016/j.bcp.2005.12.001
46. Hu, X. X.; Hao, X. H.; Wu, Y.; Zhang, J. C.; Zhang, X. N.; Wang, P. C.; Zou, G. Z.; Liang, X. J. Multifunctional Hybrid Silica Nanoparticles for Controlled Doxorubicin Loading and Release with Thermal and pH Dual Response J. Mater. Chem. B 2013, 1, 1109-1118 10.1039/c2tb00223j
47. Mosmann, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays J. Immunol. Methods 1983, 65, 55-63 10.1016/0022-1759(83)90303-4
48. Meng, J.; Xing, J.; Wang, Y.; Lu, J.; Zhao, Y.; Gao, X.; Wang, P. C.; Jia, L.; Liang, X. Epigenetic Modulation of Human Breast Cancer by Metallofullerenol Nanoparticles: In Vivo Treatment and In Vitro Analysis Nanoscale 2011, 3, 4713-4719 10.1039/c1nr10898k